The Neurostimulation Appropriateness Consensus Committee (NACC)®: Recommendations for the Mitigation of Complications of Neurostimulation
Originally published in Neuromodulation. 2024; 27: 977–1007. Translation: Eddy Gutiérrez Rojas / Milagro Coto
DOI:
https://doi.org/10.47924/neurotarget2025484Keywords:
best practices, consensus, neuromodulation, neurostimulation, spinal cord stimulationAbstract
Introduction: The International Neuromodulation Society convened a multispecialty group of physicians based on expertise and international representation to establish evidence-based guidance on the mitigation of neuromodulation complications. This Neurostimulation Appropriateness Consensus Committee (NACC)® project intends to update evidence-based guidance and offer expert opinion that will improve efficacy and safety.
Materials and Methods: Authors were chosen on the basis of their clinical expertise, familiarity with the peer-reviewed literature,,research productivity, and contributions to the neuromodulation literature. Section leaders supervised literature searches of MEDLINE, BioMed Central, Current Contents Connect, Embase, International Pharmaceutical Abstracts, Web of Science, Google Scholar, and PubMed from 2017 (when NACC last published guidelines) to October 2023. Identified studies were graded using
the United States Preventive Services Task Force criteria for evidence and certainty of net benefit. Recommendations are based on the strength of evidence or consensus when evidence was scant.
Results: The NACC examined the published literature and established evidence- and consensus-based recommendations to guide best practices. Additional guidance will occur as new evidence is developed in future iterations of this process.
Metrics
References
Deer TR, Mekhail N, Provenzano D, et al. The appropriate use of neuro-stimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee. Neuromodulation. 2014;17:515–550 [discussion: 50].
Deer TR, Mekhail N, Provenzano D, et al. The appropriate use of neurostimulation: avoidance and treatment of complications of neurostimulation therapies for the treatment of chronic pain. Neuromodulation Appropriateness Consensus Committee. Neuromodulation. 2014;17:571–597 [discussion: 97–98].
Deer TR, Krames E, Mekhail N, Pope J, Leong M, Stanton-Hicks M, et al. The appropriate use of neurostimulation: new and evolving neurostimulation therapies and applicable treatment for chronic pain and selected disease states. Neuromodulation Appropriateness Consensus Committee. Neuromodulation. 2014;17:599–615.
Deer TR, Provenzano DA, Hanes M, et al. The Neurostimulation Appropriateness Consensus Committee (NACC) recommendations for infection prevention and management. Neuromodulation. 2017;20:31–50.
Deer TR, Lamer TJ, Pope JE, et al. The Neurostimulation Appropriateness Consensus Committee (NACC) safety guidelines for the reduction of severe neurological injury. Neuromodulation. 2017;20:15–30.
Deer TR, Narouze S, Provenzano DA, et al. The Neurostimulation Appropriateness Consensus Committee (NACC): recommendations on bleeding and coagulation management in neurostimulation devices. Neuromodulation. 2017;20:51–62.
Deer TR, Pope JE, Lamer TJ, et al. The Neuromodulation Appropriateness Consensus Committee on best practices for dorsal root ganglion stimulation. Neuromodulation. 2019;22:1–35.
Deer TR, Russo M, Grider JS, et al. The Neurostimulation Appropriateness Consensus Committee (NACC): recommendations on best practices for cervical neurostimulation. Neuromodulation. 2022;25:35–52.
Deer TR, Russo MA, Grider JS, et al. The Neurostimulation Appropriateness Consensus Committee (NACC): recommendations for surgical technique for spinal cord stimulation. Neuromodulation. 2022;25:1–34.
Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(suppl):S21–S35.
Horlocker TT, Vandermeuelen E, Kopp SL, et al. Regional anesthesia in the patient receiving antithrombotic or thromolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (fourth edition). Reg Anes Pain Med. 2018;43:263–309.
Stanger MJ, Thompson LA, Young AJ, Lieberman HR. Anticoagulant activity of select dietary supplements. Nutr Rev. 2012;70:107–117.
Chiravuri S, Wasserman R, Chawla A, Haider N. Subdural hematoma following spinal cord stimulator implant. Pain Phys. 2008;11:97–101.
Giberson CE, Barbosa J, Brooks ES, et al. Epidural hematomas after removal of percutaneous spinal cord stimulator trial leads: two case reports. Reg Anesth Pain Med. 2014;39:73–77.
Levy R, Henderson J, Slavin K, et al. Incidence and avoidance of neurologic complications with paddle type spinal cord stimulation leads. Neuromodulation. 2011;14:412–422 [discussion: 422].
Petraglia FW, Farber SH, Gramer R, et al. The incidence of spinal cord injury in implantation of percutaneous and paddle electrodes for spinal cord stimulation. Neuromodulation. 2016;19:85–90.
Cameron T. Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J Neurosurg. 2004;100(suppl):S254–S267.
Mekhail NA, Mathews M, Nageeb F, Guirguis M, Mekhail MN, Cheng J. Retrospective review of 707 cases of spinal cord stimulation: indications and complications. Pain Pract. 2011;11:148–153.
Lamer TJ, Moeschler SM, Gazelka HM, Hooten WM, Bendel MA, Murad MH. Spinal stimulation for the treatment of intractable spine and limb pain: a systematic review of RCTs and meta-analysis. Mayo Clin Proc. 2019;94:1475–1487.
Shao IY, Claxton JS, Lutsey PL, Chen LY, MacLehose RF, Alonso A. Association of type of antidepressant initiation with bleeding risk in atrial fibrillation patients taking oral anticoagulants. Drugs Real World Outcomes. 2021;8:383–391.
Laporte S, Chapelle C, Caillet P, et al. Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies. Pharmacol Res. 2017;118:19–32.
Narouze S, Benzon HT, Provenzano DA, et al. Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med. 2015;40:182–212.
Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med. 2005;257:399–414.
Sibon I, Orgogozo JM. Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology. 2004;62:1187–1189.
Khan H, Kumar V, Ghulam-Jelani Z, et al. Safety of spinal cord stimulation in patients who routinely use anticoagulants. Pain Med. 2018;19:1807–1812. https://doi.org/10.1093/pm/pnx305.
Moeschler SM, Warner NS, Lamer TJ, et al. Bleeding complications in patients undergoing percutaneous spinal cord stimulator trials and implantations. Pain Med. 2016;17:2076–2081.
Lawton MT, Porter RW, Heiserman JE, Jacobowitz R, Sonntag VK, Dickman CA. Surgical management of spinal epidural hematoma: relationship between surgical timing and neurological outcome. J Neurosurg. 1995;83:1–7.
Groen RJ, van Alphen HA. Operative treatment of spontaneous spinal epidural hematomas: a study of the factors determining postoperative outcome. Neurosurgery. 1996;39:494–508 [discussion: 508].
Nammas W, Raatikainen MJP, Korkeila P, et al. Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trial. Ann Med. 2014;46:177–181.
Wiegand UKH, LeJeune D, Boguschewski F, et al. Pocket hematoma after pace-maker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest. 2004;126:1177–1186.
Tompkins C, Cheng A, Dalal D, et al. Dual antiplatelet therapy and heparin “bridging” significantly increase the risk of bleeding complications after pace-maker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol. 2010;55:2376–2382.
Michaud GF, Pelosi Jr F, Noble MD, Knight BP, Morady F, Strickberger SA. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. J Am Coll Cardiol. 2000;35:1915–1918.
Airaksinen KEJ, Korkeila P, Lund J, et al. Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment—the FinPAC study. Int J Cardiol. 2013;168:3679–3682.
Jamula E, Douketis JD, Schulman S. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide. J Thromb Haemost. 2008;6:1615–1621.
Birnie DH, Healey JS, Wells GA, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med. 2013;368:2084–2093.
Tolosana JM, Berne P, Mont L, et al. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial. Eur Heart J. 2009;30:1880–1884.
Ahmed I, Gertner E, Nelson WB, et al. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation. Heart Rhythm. 2010;7:745–749.
Li HK, Chen FC, Rea RF, et al. No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure. Pacing Clin Electrophysiol. 2011;34:868–874.
Ghanbari H, Feldman D, Schmidt M, et al. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol. 2010;33:400–406.
Nichols C, Vose JG. Incidence of bleeding-related complications during primary implantation and replacement of cardiac implantable electronic devices. J Am Heart Assoc. 2017;6:e004263.
Said SM, Esperer HD, Hahn J, et al. Influence of oral antiplatelet therapy on hemorrhagic complications of pacemaker implantation. Clin Res Cardiol. 2013;102:345–349.
Zisman E, Erport A, Kohanovsky E, et al. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. Eur J Anaesthesiol. 2010;27:617–623.
Kumar K, Hunter G, Demeria D. Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22-year experience. Neurosurgery. 2006;58:481–496 [discussion: 481–496].
Kapural L, Yu C, Doust MW, et al. Novel 10-kHz high-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain: the SENZA-RCT randomized controlled trial. Anesthesiology. 2015;123:851–860.
Barolat G. Experience with 509 plate electrodes implanted epidurally from C1 to L1. Stereotact Funct Neurosurg. 1993;61:60–79.
Deer TR, Levy RM, Kramer J, et al. Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial. Pain. 2017;158:669–681.
Morgalla MH, Fortunato M, Lepski G, Chander BS. Dorsal root ganglion stimulation (DRGS) for the treatment of chronic neuropathic pain: a single-center study with long-term prospective results in 62 cases. Pain Phys. 2018;21:E377–E387.
Deer T, Pope J, Hunter C, et al. Safety analysis of dorsal root ganglion stimulation in the treatment of chronic pain. Neuromodulation. 2020;23:239–244.
Huygen FJPM, Kallewaard JW, Nijhuis H, et al. Effectiveness and safety of dorsal root ganglion stimulation for the treatment of chronic pain: a pooled analysis. Neuromodulation. 2020;23:213–221.
Sivanesan E, Bicket MC, Cohen SP. Retrospective analysis of complications associated with dorsal root ganglion stimulation for pain relief in the FDA MAUDE database. Regional Anesthesia & Pain Medicine. 2019;44:100–106.
Eldabe S, Buchser E, Duarte RV. Complications of spinal cord stimulation and peripheral nerve stimulation techniques: a review of the literature. Pain Med. 2016;17:325–336.
Stevanato G, Devigili G, Eleopra R, et al. Chronic post-traumatic neuropathic pain of brachial plexus and upper limb: a new technique of peripheral nerve stimulation. Neurosurg Rev. 2014;37:473–479 [discussion: 479–480].
Deer T, Pope J, Benyamin R, et al. Prospective, multicenter, randomized, double-blinded, partial crossover study to assess the safety and efficacy of the novel neuromodulation system in the treatment of patients with chronic pain of peripheral nerve origin. Neuromodulation. 2016;19:91–100.
Committee on Pain Medicine, American Society of Anesthesiologists. Standards, guidelines, statements, and other documents. Statement on anesthetic care during interventional pain procedures for adults. Accessed January 3, 2024. https://www.asahq.org/standards-and-practice-parameters/statement-on-anesthetic-care-during-interventional-pain-procedures-for-adults
Schaufele MK, Marín DR, Tate JL, Simmons AC. Adverse events of conscious sedation in ambulatory spine procedures. Spine J. 2011;11:1093–1100.
Falowski S, Dianna A. Neuromonitoring protocol for spinal cord stimulator cases with case descriptions. Int J Acad Med. 2016;2(suppl 1):S132–S144.
Falowski SM, Celii A, Sestokas AK, Schwartz DM, Matsumoto C, Sharan A. Awake vs. asleep placement of spinal cord stimulators: a cohort analysis of complications associated with placement. Neuromodulation. 2011;14:130–134 [discussion:134–135].
Falowski SM, Sharan A, McInerney J, Jacobs D, Venkatesan L, Agnesi F. Nonawake vs awake placement of spinal cord stimulators: a prospective, multicenter study comparing safety and efficacy. Neurosurgery. 2019;84:198–205. https://doi.org/10.1093/neuros/nyy062.
Hwang R, Field N, Kumar V, et al. Intraoperative neuromonitoring in percutaneous spinal cord stimulator placement. Neuromodulation. 2019;22:341–346. https://doi.org/10.1111/ner.12886.
Shils JL, Arle JE. Intraoperative neurophysiologic methods for spinal cord stimulator placement under general anesthesia. Neuromodulation. 2012;15:560–571 [discussion: 571–562].
Hagedorn JM, Deer TR, Falowski SM, et al. An observational study of intraoperative neuromonitoring as a safety mechanism in placement of percutaneous dorsal root ganglion stimulation and spinal cord stimulation systems. J Pain Res. 2020;13:3349–3353.
Daniels AH, Hart RA, Hilibrand AS, et al. Latrogenic spinal cord injury resulting from cervical spine surgery. Global Spine J. 2017;7(suppl):84S–90S.
Provenzano DA, Falowski SM, Xia Y, Doth AH. Spinal cord stimulation infection rate and incremental annual expenditures: results from a United States payer database. Neuromodulation. 2019;22:302–310.
Hoelzer BC, Bendel MA, Deer TR, et al. Spinal cord stimulator implant infection rates and risk factors: a multicenter retrospective study. Neuromodulation. 2017;20:558–562.
Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther. 2004;11:354–365.
Plein L, Rittner HL. Opioids and the immune system - friend or foe. Br J Pharmacol. 2018;175:2717–2725.
Hassan Z, Nisiewicz MJ, Ueland W, et al. Preoperative opioid use and incidence of surgical site infection after repair of ventral and incisional hernias. Surgery. 2020;168:921–925.
Pirkle S, Reddy S, Bhattacharjee S, Shi LL, Lee MJ. Chronic opioid use is associated with surgical site infection after lumbar fusion. Spine. 2020;45:837–842.
Jain N, Brock JL, Malik AT, Phillips FM, Khan SN. Prediction of complications, readmission, and revision surgery based on duration of preoperative opioid use: analysis of major joint replacement and lumbar fusion. J Bone Joint Surg Am. 2019;101:384–391.
Fitzgibbon DR, Stephens LS, Posner KL, et al. Injury and liability associated with implantable devices for chronic pain. Anesthesiology. 2016;124:1384–1393.
Falowski SM, Provenzano DA, Xia Y, Doth AH. Spinal cord stimulation infection rate and risk factors: results from a United States payer database. Neuromodulation. 2019;22:179–189.
Rudiger J, Thomson S. Infection rate of spinal cord stimulators after a screening trial period. A 53-month third party follow-up. Neuromodulation. 2011;14:136–141 [discussion: 141].
Shaparin N, Gritsenko K, Agrawal P, et al. A retrospective case series of a novel spinal cord stimulator trial technique with less displacement and migration of the trial leads. Pain Res Manag. 2019;2019:1236430.
Hong B, Winkel A, Stumpp N, et al. Detection of bacterial DNA on neurostimulation systems in patients without overt infection. Clin Neurol Neurosurg. 2019;184:105399.
Lalkhen AG, Chincholkar M, Patel J. Microbiological evaluation of the extension wire and percutaneous epidural lead anchor site following a “2-stage cut-down” spinal cord stimulator procedure. Pain Pract. 2017;17:886–891.
Simopoulos T, Sharma S, Aner M, Gill JS. A temporary vs. permanent anchored percutaneous lead trial of spinal cord stimulation: a comparison of patient out-comes and adverse events. Neuromodulation. 2018;21:508–512.
Van Buyten JP, Wille F, Smet I, et al. Therapy-related explants after spinal cord stimulation: results of an international retrospective chart review study. Neuromodulation. 2017;20:642–649. https://doi.org/10.1111/ner.12642.
Logé D, De Coster O, Washburn S. Technological innovation in spinal cord stimulation: use of a newly developed delivery device for introduction of spinal cord stimulation leads. Neuromodulation. 2012;15:392–401.
North R, Desai MJ, Vangeneugden J, et al. Postoperative infections associated with prolonged spinal cord stimulation trial duration (PROMISE RCT). Neuromodulation. 2020;23:620–625.
Al-Kaisy A, Royds J, Al-Kaisy O, et al. Explant rates of electrical neuromodulation devices in 1177 patients in a single center over an 11-year period. Reg Anesth Pain Med. 2020;45:883–890.
Hayek SM, Veizi E, Hanes M. Treatment-limiting complications of percutaneous spinal cord stimulator implants: a review of eight years of experience from an academic center database. Neuromodulation. 2015;18:603–608 [discussion: 608].
Hagedorn JM, Lam CM, D’Souza RS, et al. Explantation of 10 kHz spinal cord stimulation devices: a retrospective review of 744 patients followed for at least 12 months. Neuromodulation. 2021;24:499–506.
Nolan MB, Martin DP, Thompson R, Schroeder DR, Hanson AC, Warner DO. Association between smoking status, preoperative exhaled carbon monoxide levels, and postoperative surgical site infection in patients undergoing elective surgery. JAMA Surg. 2017;152:476–483.
Sorensen LT, Karlsmark T, Gottrup F. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg. 2003;238:1–5.
Nåsell H, Adami J, Samnegård E, Tønnesen H, Ponzer S. Effect of smoking cessation intervention on results of acute fracture surgery: a randomized controlled trial. J Bone Joint Surg Am. 2010;92:1335–1342.
Myles PS, Iacono GA, Hunt JO, et al. Risk of respiratory complications and wound infection in patients undergoing ambulatory surgery: smokers versus non-smokers. Anesthesiology. 2002;97:842–847.
Møller AM, Villebro N, Pedersen T, Tønnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet. 2002;359:114–117.
Goltsman D, Munabi NCO, Ascherman JA. The association between smoking and plastic surgery outcomes in 40,465 patients: an analysis of the American College of Surgeons National Surgical Quality Improvement Program data sets. Plast Reconstr Surg. 2017;139:503–511.
Hercé B, Nazeyrollas P, Lesaffre F, et al. Risk factors for infection of implantable cardiac devices: data from a registry of 2496 patients. Europace. 2013;15:66–70.
Martin ET, Kaye KS, Knott C, et al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2016;37:88–99.
Petersen EA, Stauss TG, Scowcroft JA, et al. Effect of high-frequency (10-kHz) spinal cord stimulation in patients with painful diabetic neuropathy: a randomized clinical trial. JAMA Neurol. 2021;78:687–698. https://doi.org/10.1001/jamaneurol.2021.0538.
Clay M, Mazouyes A, Gilson M, Gaudin P, Baillet A. Risk of postoperative infections and the discontinuation of TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis. Joint Bone Spine. 2016;83:701–705.
Yassa RR, Khalfaoui MY, Veravalli K, Evans DA. Pre-operative urinary tract infection: is it a risk factor for early surgical site infection with hip fracture surgery? A retrospective analysis. JRSM Open. 2017;8:2054270416675083.
Pokrzywa CJ, Papageorge CM, Kennedy GD. Preoperative urinary tract infectionincreases postoperative morbidity. J Surg Res. 2016;205:213–220.
Mirzashahi B, Tonkaboni A, Chehrassan M, Doosti R, Kharazifard MJ. The role of poor oral health in surgical site infection following elective spinal surgery. Musculoskelet Surg. 2019;103:167–171.
Nobuhara H, Yanamoto S, Funahara M, et al. Effect of perioperative oral man-agement on the prevention of surgical site infection after colorectal cancer surgery: a multicenter retrospective analysis of 698 patients via analysis of covariance using propensity score. Medicine. 2018;97:e12545.
Yoon JS, King JT. Preoperative urinary tract infection increases postoperative morbidity in spine patients. Spine. 2020;45:747–754.
Coll PP, Lindsay A, Meng J, et al. The prevention of infections in older adults: oral health. J Am Geriatr Soc. 2020;68:411–416.
Berbari EF, Osmon DR, Carr A, et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis. 2010;50:8–16.
Martin SK, Cifu AS. Routine preoperative laboratory tests for elective surgery. JAMA. 2017;318:567–568.
Underwood P, Askari R, Hurwitz S, Chamarthi B, Garg R. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care. 2014;37:611–616.
Walid MS, Newman BF, Yelverton JC, Nutter JP, Ajjan M, Robinson JS. Prevalence of previously unknown elevation of glycosylated hemoglobin in spine surgery patients and impact on length of stay and total cost. J Hosp Med. 2010;5:E10–E14.
Halkos ME, Puskas JD, Lattouf OM, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2008;136:631–640.
Hikata T, Iwanami A, Hosogane N, et al. High preoperative hemoglobin A1c is a risk factor for surgical site infection after posterior thoracic and lumbar spinal instrumentation surgery. J Orthop Sci. 2014;19:223–228.
Ross MN, Iyer S, Gundle KR, Ross DA. Association of preoperative hemoglobin A1c and body mass index with wound infection rate in spinal surgery. Int J Spine Surg. 2021;15:811–817.
Suresh KV, Wang K, Sethi I, et al. Spine surgery and preoperative hemoglobin, hematocrit, and hemoglobin a1c: a systematic review. Global Spine J. 2022;12:155–165.
Harrop JS, Mohamed B, Bisson EF, et al. Congress of Neurological Surgeons systematic review and evidence-based guidelines for perioperative spine: pre-operative surgical risk assessment. Neurosurgery. 2021;89(suppl_1):S9–S18.
Lim S, Yeh HH, Macki M, et al. Preoperative HbA1c > 8% is associated with poor outcomes in lumbar spine surgery: a Michigan spine surgery improvement collaborative study. Neurosurgery. 2021;89:819–826.
Hwang JU, Son DW, Kang KT, et al. Importance of hemoglobin A1c levels for the detection of post-surgical infection following single-level lumbar posterior fusion in patients with diabetes. Korean J Neurotrauma. 2019;15:150–158.
Tanaka T, Bradford T, Litofsky NS. Severity of preoperative HbA1c and predicting postoperative complications in spine surgery. World Neurosurg. 2021;155:e770–e777.
Stryker LS, Abdel MP, Morrey ME, Morrow MM, Kor DJ, Morrey BF. Elevated postoperative blood glucose and preoperative hemoglobin A1C are associated with increased wound complications following total joint arthroplasty. J Bone Joint Surg Am. 2013;95:808-S2.
Godshaw BM, Warren MS, Nammour MA, Chimento GF, Mohammed AE, Waddell BS. Insulin-dependent diabetic patients are at increased risk of postoperative hyperglycemia when undergoing total joint arthroplasty. J Arthroplasty. 2020;35:2375–2379.
Usoh CO, Sherazi S, Szepietowska B, et al. Influence of diabetes mellitus on outcomes in patients after left ventricular assist device implantation. Ann Thorac Surg. 2018;106:555–560.
Habous M, Tal R, Tealab A, et al. Defining a glycated haemoglobin (HbA1c) level that predicts increased risk of penile implant infection. BJU Int. 2018;121:293–300.
Chen T, Li S, Eisenberg ML. The association between hemoglobin A1c levels and inflatable penile prosthesis infection: analysis of us insurance claims data. J Sex Med. 2021;18:1104–1109.
Zhuang T, Feng AY, Shapiro LM, Hu SS, Gardner M, Kamal RN. Is Uncontrolled diabetes mellitus associated with incidence of complications after posterior instrumented lumbar fusion? A national claims database analysis. Clin Orthop Relat Res. 2021;479:2726–2733.
Zhu X, Sun X, Zeng Y, et al. Can nasal Staphylococcus aureus screening and decolonization prior to elective total joint arthroplasty reduce surgical site and prosthesis-related infections? A systematic review and meta-analysis. J Orthop Surg Res. 2020;15:60.
Asundi A, Stanislawski M, Mehta P, et al. Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: insights from the Veterans Affairs clinical assessment reporting and tracking program. Infect Control Hosp Epidemiol. 2019;40:855–862.
Stambough JB, Nam D, Warren DK, et al. Decreased hospital costs and surgical site infection incidence with a universal decolonization protocol in primary total joint arthroplasty. J Arthroplasty. 2017;32:728–734.e1.
Rao N, Cannella BA, Crossett LS, Yates AJ, McGough RL, Hamilton CW. Preoperative screening/decolonization for Staphylococcus aureus to prevent orthopedic surgical site infection: prospective cohort study with 2-year follow-up. J Arthroplasty. 2011;26:1501–1507.
George S, Leasure AR, Horstmanshof D. Effectiveness of decolonization with chlorhexidine and Mupirocin in reducing surgical site infections: a systematic review. Dimens Crit Care Nurs. 2016;35:204–222.
Provenzano DA, Keith AD, Kilgore JS. Prevalence of Staphylococcus aureus colonization in spinal cord stimulator surgical procedures. Neuromodulation. 2023;26:1089–1094.
World Health Organization. Global guidelines for the prevention of surgical site infection. Accessed January 22, 2024. https://www.who.int/publications/i/item/9789241550475
Kowalski TJ, Kothari SN, Mathiason MA, Borgert AJ. Impact of hair removal on surgical site infection rates: a prospective randomized noninferiority trial. J Am Coll Surg. 2016;223:704–711.
Kumar K, Wilson JR, Taylor RS, Gupta S. Complications of spinal cord stimulation, suggestions to improve outcome, and financial impact. J Neurosurg Spine. 2006;5:191–203.
Najjar PA, Smink DS. Prophylactic antibiotics and prevention of surgical site infections. Surg Clin North Am. 2015;95:269–283.
Bowater RJ, Stirling SA, Lilford RJ. Is antibiotic prophylaxis in surgery a generally effective intervention? Testing a generic hypothesis over a set of meta-analyses. Ann Surg. 2009;249:551–556.
National Institute for Health and Care Excellence. NICE support for commissioning for surgical site infection. Accessed April 3, 2021. https://www.nice.org.uk/guidance/qs49/resources/surgical-site-infection-2098675107781
Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for anti-microbial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195–283.
Deer TR, Provenzano DA. Recommendations for reducing infection in the practice of implanting spinal cord stimulation and intrathecal drug delivery devices: a physician’s playbook. Pain Phys. 2013;16:E125–E128.
Matar WY, Jafari SM, Restrepo C, Austin M, Purtill JJ, Parvizi J. Preventing infection in total joint arthroplasty. J Bone Joint Surg Am. 2010;92(suppl 2):S36–S46.
de Jonge SW, Gans SL, Atema JJ, Solomkin JS, Dellinger PE, Boermeester MA. Timing of preoperative antibiotic prophylaxis in 54,552 patients and the risk of surgical site infection: a systematic review and meta-analysis. Medicine. 2017;96:e6903.
Burke JP. Maximizing appropriate antibiotic prophylaxis for surgical patients: an update from LDS Hospital, Salt Lake City. Clin Infect Dis. 2001;33(suppl 2):S78–S83.
Mehta JA, Sable SA, Nagral S. Updated recommendations for control of surgical site infections. Ann Surg. 2015;261:e65.
McDonald M, Grabsch E, Marshall C, Forbes A. Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg. 1998;68:388–396.
Ohtori S, Inoue G, Koshi T, et al. Long-term intravenous administration of antibiotics for lumbar spinal surgery prolongs the duration of hospital stay and time to normalize body temperature after surgery. Spine. 2008;33:2935–2937.
Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152:784–791.
Kappstein I, Schulgen G, Waninger J, Daschner F. Microbiological and economic studies of abbreviated procedures for surgical hand disinfection. Chirurg. 1993;64:400–405.
Wheelock SM, Lookinland S. Effect of surgical hand scrub time on subsequent bacterial growth. AORN J. 1997;65:1087–1092;1094–1092.
Pereira LJ, Lee GM, Wade KJ. An evaluation of five protocols for surgical hand-washing in relation to skin condition and microbial counts. J Hosp Infect. 1997;36:49–65.
Poon C, Morgan DJ, Pond F, Kane J, Tulloh BR. Studies of the surgical scrub. Aust N Z J Surg. 1998;68:65–67.
Furukawa K, Tajiri T, Suzuki H, Norose Y. Are sterile water and brushes necessary for hand washing before surgery in Japan? J Nippon Med Sch. 2005;72:149–154.
Pereira LJ, Lee GM, Wade KJ. The effect of surgical handwashing routines on the microbial counts of operating room nurses. Am J Infect Control. 1990;18:354–364.
Tsai JC, Lin YK, Huang YJ, et al. Antiseptic effect of conventional povidone-iodine scrub, chlorhexidine scrub, and waterless hand rub in a surgical room: a randomized controlled trial. Infect Control Hosp Epidemiol. 2017;38:417–422.
Parienti JJ, Thibon P, Heller R, et al. Hand-rubbing with an aqueous alcoholic solution vs traditional surgical hand-scrubbing and 30-day surgical site infection rates: a randomized equivalence study. JAMA. 2002;288:722–727.
Nthumba PM, Stepita-Poenaru E, Poenaru D, et al. Cluster-randomized, crossover trial of the efficacy of plain soap and water versus alcohol-based rub for surgical hand preparation in a rural hospital in Kenya. Br J Surg. 2010;97:1621–1628.
Gaspar GG, Menegueti MG, Lopes AER, et al. Alcohol-based surgical hand preparation: translating scientific evidence into clinical practice. Antimicrob Resist Infect Control. 2018;7:80.
Iwakiri K, Kobayashi A, Seki M, et al. Waterless hand rub versus traditional hand scrub methods for preventing the surgical site infection in orthopedic surgery. Spine. 2017;42:1675–1679.
Pires D, Soule H, Bellissimo-Rodrigues F, Gayet-Ageron A, Pittet D. Hand hygiene with alcohol-based hand rub: how long is long enough? Infect Control Hosp Epidemiol. 2017;38:547–552.
Salisbury DM, Hutfilz P, Treen LM, Bollin GE, Gautam S. The effect of rings on microbial load of health care workers’ hands. Am J Infect Control. 1997;25:24–27.
Pottinger J, Burns S, Manske C. Bacterial carriage by artificial versus natural nails. Am J Infect Control. 1989;17:340–344.
Passaro DJ, Waring L, Armstrong R, et al. Postoperative Serratia marcescens wound infections traced to an out-of-hospital source. J Infect Dis. 1997;175:992–995.
Wynd CA, Samstag DE, Lapp AM. Bacterial carriage on the fingernails of OR nurses. AORN J. 1994;60:796–805.
Esquer Garrigos Z, Farid S, Bendel MA, Sohail MR. Spinal cord stimulator infection: approach to diagnosis, management, and prevention. Clin Infect Dis. 2020;70:2727–2735.
Lio PA, Kaye ET. Topical antibacterial agents. Med Clin North Am. 2011;95:703–721.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999;27:97–132. quiz 133.
Dumville JC, McFarlane E, Edwards P, Lipp A, Holmes A, Liu Z. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev. 2015;2015:CD003949.
Edmiston CE, Bruden B, Rucinski MC, Henen C, Graham MB, Lewis BL. Reducing the risk of surgical site infections: does chlorhexidine gluconate provide a risk reduction benefit? Am J Infect Control. 2013;41(suppl):S49–S55.
Ostrander RV, Botte MJ, Brage ME. Efficacy of surgical preparation solutions in foot and ankle surgery. J Bone Joint Surg Am. 2005;87:980–985.
Saltzman MD, Nuber GW, Gryzlo SM, Marecek GS, Koh JL. Efficacy of surgical preparation solutions in shoulder surgery. J Bone Joint Surg Am. 2009;91:1949–1953.
Darouiche RO, Wall MJ, Itani KMF, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362:18–26.
Lee I, Agarwal RK, Lee BY, Fishman NO, Umscheid CA. Systematic review and cost analysis comparing use of chlorhexidine with use of iodine for preoperative skin antisepsis to prevent surgical site infection. Infect Control Hosp Epidemiol. 2010;31:1219–1229.
PREP-IT Investigators, Sprague S, Slobogean G, et al. Skin antisepsis before surgical fixation of extremity fractures. N Engl J Med. 2024;390:409–420.
Davies BM, Patel HC. Does chlorhexidine and povidone-iodine preoperative antisepsis reduce surgical site infection in cranial neurosurgery? Ann R Coll Surg Engl. 2016;98:405–408.
Davies BM, Patel HC. Systematic review and meta-analysis of preoperative anti-sepsis with combination chlorhexidine and povidone-iodine. Surg J (N Y). 2016;2:e70–e77.
Sviggum HP, Jacob AK, Arendt KW, Mauermann ML, Horlocker TT, Hebl JR. Neurologic complications after chlorhexidine antisepsis for spinal anesthesia. Reg Anesth Pain Med. 2012;37:139–144.
Cowles CE, Chiang JL. Flammable surgical preps require vigilance. Anesthesia Patient Safety Foundation. 2014;29:25–40.
Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(suppl 2):S165–S193.
National Institute for Health and Care Excellence. Surgical site infections: prevention and treatment. Accessed July 21, 2020. https://www.nice.org.uk/guidance/ng125
Philips BJ, Fergusson S, Armstrong P, Anderson FM, Wildsmith JA. Surgical face masks are effective in reducing bacterial contamination caused by dispersal from the upper airway. Br J Anaesth. 1992;69:407–408.
Dineen P, Drusin L. Epidemics of postoperative wound infections associated with hair carriers. Lancet. 1973;2:1157–1159.
Mastro TD, Farley TA, Elliott JA, et al. An outbreak of surgical-wound infections due to group A streptococcus carried on the scalp. N Engl J Med. 1990;323:968–972.
Tanner J, Parkinson H. Double gloving to reduce surgical cross-infection. Cochrane Database Syst Rev. 2006;3:CD003087.
Ward WG, Cooper JM, Lippert D, Kablawi RO, Neiberg RH, Sherertz RJ. Glove and gown effects on intraoperative bacterial contamination. Ann Surg. 2014;259:591–597.
Beldame J, Lagrave B, Lievain L, Lefebvre B, Frebourg N, Dujardin F. Surgical glove bacterial contamination and perforation during total hip arthroplasty implantation: when gloves should be changed. Orthop Traumatol Surg Res. 2012;98:432–440.
Lidwell OM, Lowbury EJ, Whyte W, Blowers R, Stanley SJ, Lowe D. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br Med J (Clin Res Ed). 1982;285:10–14.
Lidwell OM, Lowbury EJ, Whyte W, Blowers R, Stanley SJ, Lowe D. Ventilation in operating rooms. Br Med J (Clin Res Ed). 1983;286:1214–1215.
Lidwell OM, Lowbury EJ, Whyte W, Blowers R, Stanley SJ, Lowe D. Infection and sepsis after operations for total hip or knee-joint replacement: influence of ultraclean air, prophylactic antibiotics and other factors. J Hyg (Lond). 1984;93:505–529.
Lidwell OM. Clean air at operation and subsequent sepsis in the joint. Clin Orthop Relat Res. 1986:91–102.
Knobben BA, van Horn JR, van der Mei HC, Busscher HJ. Evaluation of measures to decrease intra-operative bacterial contamination in orthopaedic implant surgery. J Hosp Infect. 2006;62:174–180.
Gruenberg MF, Campaner GL, Sola CA, Ortolan EG. Ultraclean air for prevention of postoperative infection after posterior spinal fusion with instrumentation: a comparison between surgeries performed with and without a vertical exponential filtered air-flow system. Spine. 2004;29:2330–2334.
Alijanipour P, Karam J, Llinás A, et al. Operative environment. J Orthop Res. 2014;32(suppl 1):S60–S80.
Andersson AE, Bergh I, Karlsson J, Eriksson BI, Nilsson K. Traffic flow in the operating room: an explorative and descriptive study on air quality during orthopedic trauma implant surgery. Am J Infect Control. 2012;40:750–755.
Davis N, Curry A, Gambhir AK, et al. Intraoperative bacterial contamination in operations for joint replacement. J Bone Joint Surg Br. 1999;81:886–889.
Hussein JR, Villar RN, Gray AJ, Farrington M. Use of light handles in the laminar flow operating theatre—is it a cause of bacterial concern? Ann R Coll Surg Engl. 2001;83:353–354.
Biswas D, Bible JE, Whang PG, Simpson AK, Grauer JN. Sterility of C-arm fluoroscopy during spinal surgery. Spine. 2008;33:1913–1917.
Johnston DH, Fairclough JA, Brown EM, Morris R. Rate of bacterial recolonization of the skin after preparation: four methods compared. Br J Surg. 1987;74:64.
Webster J, Alghamdi AA. Use of plastic adhesive drapes during surgery for preventing surgical site infection. Cochrane Database Syst Rev. 2007;2019:CD006353.
Levy JH, Nagle DM, Curling PE, Waller JL, Kopel M, Tobia V. Contamination reduction during central venous catheterization. Crit Care Med. 1988;16:165–167.
Geelhoed GW, Sharpe K, Simon GL. A comparative study of surgical skin preparation methods. Surg Gynecol Obstet. 1983;157:265–268.
Fairclough JA, Johnson D, Mackie I. The prevention of wound contamination by skin organisms by the pre-operative application of an iodophor impregnated plastic adhesive drape. J Int Med Res. 1986;14:105–109.
Rezapoor M, Tan TL, Maltenfort MG, Parvizi J. Incise draping reduces the rate of contamination of the surgical site during hip surgery: a prospective, randomized trial. J Arthroplasty. 2018;33:1891–1895.
Fletcher N, Sofianos D, Berkes MB, Obremskey WT. Prevention of perioperative infection. J Bone Joint Surg Am. 2007;89:1605–1618.
Ritter MA, Campbell ED. Retrospective evaluation of an iodophor-incorporated antimicrobial plastic adhesive wound drape. Clin Orthop Relat Res. 1988:307–308.
Casey AL, Karpanen TJ, Nightingale P, Conway BR, Elliott TS. Antimicrobial activity and skin permeation of iodine present in an iodine-impregnated surgical incise drape. J Antimicrob Chemother. 2015;70:2255–2260.
Chin KR, London N, Gee AO, Bohlman HH. Risk for infection after anterior cervical fusion: prevention with iodophor-impregnated incision drapes. Am J Orthop (Belle Mead NJ). 2007;36:433–435.
Yoshimura Y, Kubo S, Hirohashi K, et al. Plastic iodophor drape during liver surgery operative use of the iodophor-impregnated adhesive drape to prevent wound infection during high risk surgery. World J Surg. 2003;27:685–688.
Dewan PA, Van Rij AM, Robinson RG, Skeggs GB, Fergus M. The use of an iodophor-impregnated plastic incise drape in abdominal surgery–a controlled clinical trial. Aust N Z J Surg. 1987;57:859–863.
Segal CG, Anderson JJ. Preoperative skin preparation of cardiac patients. AORN. 2002;76:821–828.
Surgical site infection (SSI) event. Centers for Disease Control and Prevention: National Healthcare Safety Network. Atlanta, GA: CDC; 2013.
Cruse PJ, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am. 1980;60:27–40.
Haley RW, Culver DH, Morgan WM, White JW, Emori TG, Hooton TM. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol. 1985;121:206–215.
Olson M, O’Connor M, Schwartz ML. Surgical wound infections. A 5-year prospective study of 20,193 wounds at the Minneapolis VA Medical Center. Ann Surg. 1984;199:253–259.
Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National nosocomial infections surveillance system. Am J Med. 1991;91:152S–157S.
Zhu J, Gutman G, Collins JG, Colonna J. A review of surgical techniques in spinal cord stimulator implantation to decrease the post-operative infection rate. J Spine. 2014;4:1–12.
Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of wound infection and temperature group. N Engl J Med. 1996;334:1209–1215.
Soballe PW, Nimbkar NV, Hayward I, Nielsen TB, Drucker WR. Electric cautery lowers the contamination threshold for infection of laparotomies. Am J Surg. 1998;175:263–266.
Rongetti RL, Oliveira e Castro Pde T, Vieira RA, et al. Surgical site infection: an observer-blind, randomized trial comparing electrocautery and conventional scalpel. Int J Surg. 2014;12:681–687.
Ismail A, Abushouk AI, Elmaraezy A, et al. Cutting electrocautery versus scalpel for surgical incisions: a systematic review and meta-analysis. J Surg Res. 2017;220:147–163.
Aird LNF, Brown CJ. Systematic review and meta-analysis of electrocautery versus scalpel for surgical skin incisions. Am J Surg. 2012;204:216–221.
Shamim M. Diathermy vs. scalpel skin incisions in general surgery: double-blind, randomized, clinical trial. World J Surg. 2009;33:1594–1599.
Kearns SR, Connolly EM, McNally S, McNamara DA, Deasy J. Randomized clinical trial of diathermy versus scalpel incision in elective midline laparotomy. Br J Surg. 2001;88:41–44.
Barnes S, Spencer M, Graham D, Johnson HB. Surgical wound irrigation: a call for evidence-based standardization of practice. Am J Infect Control. 2014;42:525–529.
Savage JW, Weatherford BM, Sugrue PA, et al. Efficacy of surgical preparation solutions in lumbar spine surgery. J Bone Joint Surg Am. 2012;94:490–494.
Norman G, Atkinson RA, Smith TA, et al. Intracavity lavage and wound irrigation for prevention of surgical site infection. Cochrane Database Syst Rev. 2017;10:CD012234.
Hassinger SM, Harding G, Wongworawat MD. High-pressure pulsatile lavage propagates bacteria into soft tissue. Clin Orthop Relat Res. 2005;439:27–31.
Bercial ME, Sabino Neto M, Calil JA, Rossetto LA, Ferreira LM. Suction drains, quilting sutures, and fibrin sealant in the prevention of seroma formation in abdominoplasty: which is the best strategy? Aesthetic Plast Surg. 2012;36:370–
Bailey SH, Oni G, Guevara R, Wong C, Saint-Cyr M. Latissimus dorsi donor-site morbidity: the combination of quilting and fibrin sealant reduce length of drain placement and seroma rate. Ann Plast Surg. 2012;68:555–558.
Aho JM, Nickerson TP, Thiels CA, Saint-Cyr M, Farley DR. Prevention of post-operative seromas with dead space obliteration: a case-control study. Int J Surg. 2016;29:70–73.
Heal CF, Banks JL, Lepper PD, Kontopantelis E, van Driel ML. Topical antibiotics for preventing surgical site infection in wounds healing by primary intention. Cochrane Database Syst Rev. 2016;11:CD011426.
Dire DJ, Coppola M, Dwyer DA, Lorette JJ, Karr JL. Prospective evaluation of topical antibiotics for preventing infections in uncomplicated soft-tissue wounds repaired in the ED. Acad Emerg Med. 1995;2:4–10.
Shapiro JM, Bond EL, Garman JK. Use of a chlorhexidine dressing to reduce microbial colonization of epidural catheters. Anesthesiology. 1990;73:625–631.
Mann TJ, Orlikowski CE, Gurrin LC, Keil AD. The effect of the Biopatch, a chlorhexidine impregnated dressing, on bacterial colonization of epidural catheter exit sites. Anaesth Intensive Care. 2001;29:600–603.
Ho KM, Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother. 2006;58:281–287.
Levine DP. Vancomycin: a history. Clin Infect Dis. 2006;42(suppl 1):S5–S12.
Malheiro L, Gomes A, Barbosa P, Santos L, Sarmento A. Infectious complications of intrathecal drug administration systems for spasticity and chronic pain: 145 patients from a tertiary care center. Neuromodulation. 2015;18:421–427.
Bendersky D, Yampolsky C. Is spinal cord stimulation safe? A review of its complications. World Neurosurg. 2014;82:1359–1368.
Bendel MA, O’Brien T, Hoelzer BC, et al. Spinal cord stimulator related infections: findings from a multicenter retrospective analysis of 2737 implants. Neuromodulation. 2017;20:553–557.
Vander Salm TJ, Okike ON, Pasque MK, et al. Reduction of sternal infection by application of topical vancomycin. J Thorac Cardiovasc Surg. 1989;98:618–622.
Chiang HY, Herwaldt LA, Blevins AE, Cho E, Schweizer ML. Effectiveness of local vancomycin powder to decrease surgical site infections: a meta-analysis. Spine J. 2014;14:397–407.
Xiong L, Pan Q, Jin G, Xu Y, Hirche C. Topical intrawound application of vancomycin powder in addition to intravenous administration of antibiotics: a meta-analysis on the deep infection after spinal surgeries. Orthop Traumatol Surg Res. 2014;100:785–789.
Bakhsheshian J, Dahdaleh NS, Lam SK, Savage JW, Smith ZA. The use of vancomycin powder in modern spine surgery: systematic review and meta-analysis of the clinical evidence. World Neurosurg. 2015;83:816–823.
Khan NR, Thompson CJ, DeCuypere M, et al. A meta-analysis of spinal surgical site infection and vancomycin powder. J Neurosurg Spine. 2014;21:974–983.
Kang DG, Holekamp TF, Wagner SC, Lehman RA. Intrasite vancomycin powder for the prevention of surgical site infection in spine surgery: a systematic literature review. Spine J. 2015;15:762–770.
Tubaki VR, Rajasekaran S, Shetty AP. Effects of using intravenous antibiotic only versus local intrawound vancomycin antibiotic powder application in addition to intravenous antibiotics on postoperative infection in spine surgery in 907 patients. Spine. 2013;38:2149–2155.
Amrani J. Intraoperative powdered vancomycin use with paddle lead placement. Neoromodulation. 2015;18:177–180 [discussion: 181].
Sullivan KH, Kurra S, DeMercurio PJ, et al. Effect of vancomycin on postoperative infection rates in thoracic spinal cord stimulation implants. Spine. 2018;18(suppl): S151.
Mittal S, Shaw RE, Michel K, et al. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope. Heart Rhythm. 2014;11:595–601.
Kolek MJ, Dresen WF, Wells QS, Ellis CR. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients. Pacing Clin Electrophysiol. 2013;36:354–361.
Kolek MJ, Patel NJ, Clair WK, et al. Efficacy of a bio-absorbable antibacterial envelope to prevent cardiac implantable electronic device infections in high-risk subjects. J Cardiovasc Electrophysiol. 2015;26:1111–1116.
Tarakji KG, Mittal S, Kennergren C, et al. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med. 2019;380:1895–1905.
Hagedorn JM, Canzanello N, Bendel MA, P Pittelkow T, J Lamer T. Antibacterial envelope use for the prevention of surgical site infection in spinal cord stimulator implantation surgery: a retrospective review of 52 cases. J Pain Res. 2021;14:2249–2254.
Hutchinson JJ, McGuckin M. Occlusive dressings: a microbiologic and clinical review. Am J Infect Control. 1990;18:257–268.
Rheinecker SB. Wound management: the occlusive dressing. J Athl Train. 1995;30:143–146.
Takashima M, Ray-Barruel G, Ullman A, Keogh S, Rickard CM. Randomized controlled trials in central vascular access devices: a scoping review. PLOS ONE. 2017;12:e0174164.
Walter CJ, Dumville JC, Sharp CA, Page T. Systematic review and meta-analysis of wound dressings in the prevention of surgical-site infections in surgical wounds healing by primary intention. Br J Surg. 2012;99:1185–1194.
Dumville JC, Gray TA, Walter CJ, et al. Dressings for the prevention of surgical site infection. Cochrane Database Syst Rev. 2011:CD003091.
Deer TR, Stewart C. Complications of spinal cord stimulation: identification, treatment and prevention. Pain Med. 2008;9:S93–S101.
Bullocks J, Basu C, Hsu P, Singer R. Prevention of hematomas and seromas. Semin Plast Surg. 2006;20:233–240.
Normansell DE, Stacy EK, Booker CF, Butler TZ. Detection of beta-2 transferrin in otorrhea and rhinorrhea in a routine clinical laboratory setting. Clin Diagn Lab Immunol. 1994;1:68–70.
Oakley GM, Alt JA, Schlosser RJ, Harvey RJ, Orlandi RR. Diagnosis of cerebrospinal fluid rhinorrhea: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2016;6:8–16.
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.
Kruidenier J, Dingemans SA, Van Dieren S, De Jong VM, Goslings JC, Schepers T. C-reactive protein kinetics and its predictive value in orthopedic (trauma) surgery: a systematic review. Acta Orthop Belg. 2018;84:397–406.
Chrintz H, Vibits H, Cordtz TO, Harreby JS, Waaddegaard P, Larsen SO. Need for surgical wound dressing. Br J Surg. 1989;76:204–205.
Coffey RJ, Owens ML, Broste SK, et al. Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain. Pain Med. 2010;11:1001–1009.
Piper KE, Fernandez-Sampedro M, Steckelberg KE, et al. C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infection. PLOS ONE. 2010;5:e9358.
Mok JM, Pekmezci M, Piper SL, et al. Use of C-reactive protein after spinal surgery: comparison with erythrocyte sedimentation rate as predictor of early post-operative infectious complications. Spine. 2008;33:415–421.
Jönsson B, Söderholm R, Strömqvist B. Erythrocyte sedimentation rate after lumbar spine surgery. Spine. 1991;16:1049–1050.
Pradilla G, Nagahama Y, Spivak AM, Bydon A, Rigamonti D. Spinal epidural abscess: current diagnosis and management. Curr Infect Dis Rep. 2010;12:484–491.
Sandoe JA, Barlow G, Chambers JB, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother. 2015;70:325–359.
Torrens JK, Stanley PJ, Ragunathan PL, Bush DJ. Risk of infection with electrical spinal-cord stimulation. Lancet. 1997;349:729.
Jiang Z, Wang Y, Jiang Y, Xu Y, Meng B. Vertebral osteomyelitis and epidural abscess due to Aspergillus nidulans resulting in spinal cord compression: case report and literature review. J Int Med Res. 2013;41:502–510.
Bedder MD, Bedder HF. Spinal cord stimulation surgical technique for the nonsurgically trained. Neuromodulation. 2009;12(suppl 1):S1–S19.
Russo A, Concia E, Cristini F, et al. Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. Clin Microbiol Infect. 2016;22(suppl 2):S27–S36.
Talan DA, Mower WR, Krishnadasan A, et al. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med. 2016;374:823–832.
Plymale MA, Harris JW, Davenport DL, Smith N, Levy S, Scott Roth J. Abdominal wall reconstruction: the uncertainty of the impact of drain duration upon out-comes. Am Surg. 2016;82:207–211.
Cotogni P, Barbero C, Rinaldi M. Deep sternal wound infection after cardiac surgery: evidences and controversies. World J Crit Care Med. 2015;4:265–273.
Eltorai AEM, Naqvi SS, Seetharam A, Brea BA, Simon C. Recent developments in the treatment of spinal epidural abscesses. Orthop Rev (Pavia). 2017;9:7010.
Sendi P, Bregenzer T, Zimmerli W. Spinal epidural abscess in clinical practice. Qjm. 2008;101:1–12.
Tompkins M, Panuncialman I, Lucas P, Palumbo M. Spinal epidural abscess. J Emerg Med. 2010;39:384–390.
Boviatsis EJ, Kouyialis AT, Boutsikakis I, Korfias S, Sakas DE. Infected CNS infusion pumps. Is there a chance for treatment without removal? Acta Neurochir. 2004;146:463–467.
Hester SM, Fisher JF, Lee MR, Macomson S, Vender JR. Evaluation of salvage techniques for infected baclofen pumps in pediatric patients with cerebral palsy. J Neurosurg Pediatr. 2012;10:548–554.
Atiyeh BS, Hayek SN, Skaf GS, Al Araj A, Chamoun RB. Baclofen pump pocket infection: a case report of successful salvage with muscle flap. Int Wound J. 2006;3:23–28.
Ooi YC, Saulino M, Williams KA, Sharan A. Observational analysis of successful reimplantation of explanted intrathecal drug delivery systems: a case series. PM R. 2011;3:175–178.
Provenzano DA, Deer T, Luginbuhl Phelps A, et al. An international survey to understand infection control practices for spinal cord stimulation. Neuromodulation. 2016;19:71–84.
Blomström-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by
the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020;22:515–549.
Baddour LM, Epstein AE, Erickson CC, et al. A summary of the update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. J Am Dent Assoc. 2011;142:159–165.
Deer TR, Pope JE. Complications of spinal cord stimulation. In: Deer TR, Pope JE, eds. Atlas of Implantable Therapies for Pain Management. Springer; 2016:93–103.
Azeem N. Neuromodulation: optimizing surgical outcomes and risk reduction. In: Diwan S, Deer TR, eds. Advanced Pro Pain Manag. Springer; 2018:123–134.
North RB, Ewend MG, Lawton MT, Piantadosi S. Spinal cord stimulation for chronic, intractable pain: superiority of “multi-channel” devices. Pain. 1991;44:119–130.
North RB, Kidd DH, Zahurak M, James CS, Long DM. Spinal cord stimulation for chronic, intractable pain: experience over two decades. Neurosurgery. 1993;32:384–394. [discussion: 394–395]. https://doi.org/10.1227/00006123-199303000-00008.
Heidecke V, Rainov NG, Burkert W. Hardware failures in spinal cord stimulation for failed back surgery syndrome. Neuromodulation. 2000;3:27–30. https://doi.org/10.1046/j.1525-1403.2000.00027.x.
Sears NC, Machado AG, Nagel SJ, et al. Long-term outcomes of spinal cord stimulation with paddle leads in the treatment of complex regional pain syndrome and failed back surgery syndrome. Neuromodulation. 2011;14:312–318 [discussion: 318].
North RB, Kidd DH, Olin J, et al. Spinal cord stimulation for axial low back pain: a prospective, controlled trial comparing dual with single percutaneous electrodes. Spine. 2005;30:1412–1418. https://doi.org/10.1097/01brs.0000166502.05449.a8.
Rainov NG, Heidecke V. Hardware failures in spinal cord stimulation (SCS) for chronic benign pain of spinal origin. Acta Neurochir Suppl. 2007;97:101–104. https://doi.org/10.1007/978-3-211-33079-1_13.
Vasques X, Tancu C, Cif L, et al. Cerebral magnetic resonance imaging feasibility in patients with implanted neurostimulation system for deep brain stimulation. Open Magn Reson J. 2008;1:1–8.
Tagliati M, Jankovic J, Pagan F, et al. Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage. 2009;47(suppl 2):T53–T57. https://doi.org/10.1016/j.neuroimage.2009.04.044.
Pope JE, Deer TR, Falowski S, et al. Multicenter retrospective study of neurostimulation with exit of therapy by explant. Neuromodulation. 2017;20:543–552. https://doi.org/10.1111/ner.12634.
Rosenow JM, Stanton-Hicks M, Rezai AR, Henderson JM. Failure modes of spinal cord stimulation hardware. J Neurosurg Spine. 2006;5:183–190. https://doi.org/10.3171/spi.2006.5.3.183.
Abejón D, Cameron T, Feler C, Pérez-Cajaraville J. Electric parameters optimization in spinal cord stimulation. Study in conventional nonrechargeable systems. Neuromodulation. 2010;13:281–286 [discussion: 286]. https://doi.org/10.1111/j.1525-1403.2010.00290.x
Provenzano DA, Rebman J, Kuhel C, Trenz H, Kilgore J. The efficacy of high-density spinal cord stimulation among trial, implant, and conversion patients: a retrospective case series. Neuromodulation. 2017;20:654–660. https://doi.org/10.1111/ner.12612.
De Jaeger M, van Hooff RJ, Goudman L, et al. High-density in spinal cord stimulation: virtual expert registry (discover): study protocol for a prospective observational trial. Anesth Pain Med. 2017;7:e13640. https://doi.org/10.5812/ apm.13640.
North JM, Hong KJ, Cho PY. Clinical outcomes of 1 kHz subperception spinal cord stimulation in implanted patients with failed paresthesia-based stimulation: results of a prospective randomized controlled trial. Neuromodulation. 2016;19:731–737. https://doi.org/10.1111/ner.12441.
Kapural L, Harandi S. Long-term efficacy of 1–1.2 kHz subthreshold spinal cord stimulation following failed traditional spinal cord stimulation: a retrospective case series. Reg Anesth Pain Med. 2019;44:107–110. https://doi.org/10.1136/rapm-2018-000003.
Lind G, Meyerson BA, Winter J, Linderoth B. Intrathecal baclofen as adjuvant therapy to enhance the effect of spinal cord stimulation in neuropathic pain: a pilot study. Eur J Pain. 2004;8:377–383. https://doi.org/10.1016/j.ejpain.2003.11.002.
Claydon LS, Chesterton LS, Barlas P, Sim J. Alternating-frequency TENS effects on experimental pain in healthy human participants: a randomized placebo-controlled trial. Clin J Pain. 2013;29:533–539. https://doi.org/10.1097/AJP.0b013e318262330f.
Haider N, Ligham D, Quave B, et al. Spinal cord stimulation (SCS) trial outcomes after conversion to a multiple waveform SCS system. Neuromodulation. 2018;21:504–507. https://doi.org/10.1111/ner.12783.
Duse G, Reverberi C, Dario A. Effects of multiple waveforms on patient preferences and clinical outcomes in patients treated with spinal cord stimulation for leg and/or back pain. Neuromodulation. 2019;22:200–207.
Berg AP, Mekel-Bobrov N, Goldberg E, Huynh D, Jain R. Utilization of multiple spinal cord stimulation (SCS) waveforms in chronic pain patients. Expert Rev Med Devices. 2017;14:663–668.
Bennett DS, Aló KM, Oakley J, Feler CA. Spinal cord stimulation for complex regional pain syndrome I [RSD]: a retrospective multicenter experience from 1995 to 1998 of 101 patients. Neuromodulation. 1999;2:202–210.
Reddy RD, Moheimani R, Yu GG, Chakravarthy KV. A review of clinical data on salvage therapy in spinal cord stimulation. Neuromodulation. 2020;23:562–571. https://doi.org/10.1111/ner.13067.
Ghosh P, Simopoulos T. High frequency spinal cord stimulation (HF−SCS) at 10 kHz as salvage therapy for unsuccessful traditional spinal cord stimulator trials and implantsAbstract presented at:International Neuromodulation Societymeeting, Sydney, Australia. 2019.
De Ridder D, Lenders MWPM, De Vos CC, et al. A 2-center comparative study on tonic versus burst spinal cord stimulation: amount of responders and amount of pain suppression. Clin J Pain. 2015;31:433–437. https://doi.org/10.1097/AJP.0000000000000129.
Courtney P, Espinet A, Mitchell B, et al. Improved pain relief with burst spinal cord stimulation for two weeks in patients using tonic stimulation: results from a small clinical study. Neuromodulation. 2015;18:361–366. https://doi.org/10.1111/ner.12294.
de Vos CC, Bom MJ, Vanneste S, Lenders MWPM, de Ridder D. Burst spinal cord stimulation evaluated in patients with failed back surgery syndrome and painful diabetic neuropathy. Neuromodulation. 2014;17:152–159. https://doi.org/10.1111/ner.12116.
Hunter CW, Carlson J, Yang A, et al. BURST(able): a retrospective, multicenter study examining the impact of spinal cord stimulation with burst on pain and opioid consumption in the setting of salvage treatment and “upgrade”. Pain Phys. 2020;23:E643–E658.
Deer TR, Patterson DG, Baksh J, et al. Novel intermittent dosing burst paradigm in spinal cord stimulation. Neuromodulation. 2021;24:566–573.
Hagedorn JM, Engle AM, Ghosh P, R Deer T. Device profile of the Proclaim XR neurostimulation system for the treatment of chronic pain: an overview of its safety and efficacy. Expert Rev Med Devices. 2020;17:499–505. https://doi.org/10.1080/17434440.2020.1773258.
Dietvorst S, Decramer T, Lemmens R, Morlion B, Nuttin B, Theys T. Pocket pain and neuromodulation: negligible or neglected? Neuromodulation. 2017;20:600–605.
Mehta SH, Hoelscher CM, Sharan AD, Thalheimer S, Wu C. Implantable pulse generator site may be associated with spinal cord stimulation revision surgeries. Neuromodulation. 2021;24:1336–1340.
Turner JA, Loeser JD, Deyo RA, Sanders SB. Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: a systematic review of effectiveness and complications. Pain. 2004;108:137–147.
Wolter T, Kieselbach K. Cervical spinal cord stimulation: an analysis of 23 patients with long-term follow-up. Pain Phys. 2012;15:203–212.
Van Buyten JP, Al-Kaisy A, Smet I, Palmisani S, Smith T. High-frequency spinal cord stimulation for the treatment of chronic back pain patients: results of a prospective multicenter European clinical study. Neuromodulation. 2013;16:59–65 [discussion: 65].
de Vos CC, Meier K, Zaalberg PB, et al. Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain. 2014;155:2426–2431.
Shamji MF, Westwick HJ, Heary RF. Complications related to the use of spinal cord stimulation for managing persistent postoperative neuropathic pain after lumbar spinal surgery. Neurosurg Focus. 2015;39:E15.
De Andres J, Monsalve-Dolz V, Fabregat-Cid G, et al. Prospective, randomized blind effect-on-outcome study of conventional vs high-frequency spinal cord stimulation in patients with pain and disability due to failed back surgery syndrome. Pain Med. 2017;18:2401–2421.
Baranidharan G, Bretherton B, Richert G, et al. Pocket pain, does location matter: a single-centre retrospective study of patients implanted with a spinal cord stimulator. Reg Anesth Pain Med. 2020;45:891–897.
Gofeld M, McQueen CK. Ultrasound-guided intrathecal pump access and prevention of the pocket fill. Pain Med. 2011;12:607–611.
Dupoiron D, Douillard T, Carvajal G. Usefulness of imaging for intrathecal drug delivery systems: an update. MRAJ. 2020;8.
Asensio-Samper JM, De Andrés-Ibáñez J, Fabregat Cid G, Villanueva Pérez V, Alarcón L. Ultrasound-guided transversus abdominis plane block for spinal infusion and neurostimulation implantation in two patients with chronic pain. Pain Pract. 2010;10:158–162.
Cruickshank RH, Hopkinson JM. Fluid flow through dural puncture sites. An in vitro comparison of needle point types. Anaesthesia. 1989;44:415–418.
Freeman ED, Hoelzer BC, Eldrige JS, Moeschler SM. Fibrin glue to treat spinal fluid leaks associated with intrathecal drug systems. Pain Pract. 2014;14:570–576. https://doi.org/10.1111/papr.12151.
Turnbull DK, Shepherd DB. Post-dural puncture headache: pathogenesis, prevention and treatment. Br J Anaesth. 2003;91:718–729. https://doi.org/10.1093/bja/aeg231.
Eldrige JS, Weingarten TN, Rho RH. Management of cerebral spinal fluid leak
complicating spinal cord stimulator implantation. Pain Pract. 2006;6:285–288.
Kawaguchi M, Hashizume K, Watanabe K, Inoue S, Furuya H. Fluoroscopically guided epidural blood patch in patients with postdural puncture headache after spinal and epidural anesthesia. J Anesth. 2011;25:450–453.
Choi H, Gaiha R, Moeschler SM, et al. Factors associated with implantable pulse generator site pain: a multicenter cross-sectional study. Neuromodulation. 2021;
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Timothy R. Deer, Marc A. Russo, Dawood Sayed, Jason E. Pope, Jay S. Grider, Jonathan M. Hagedorn, Steven M. Falowski, Adnan Al-Kaisy, Konstantin V. Slavin, Sean Li, Lawrence R. Poree, Sam Eldabe, Kaare Meier, Tim J. Lamer, Julie G. Pilitsis, José De Andrés, Christophe Perruchoud, Alexios G. Carayannopoulos, Susan M. Moeschler, Amir Hadanny, Eric Lee, Vishal P. Varshney, Mehul J. Desai, Peter Pahapill, J. Osborn, Stana Bojanic, Ajay Antony, Fabian Piedimonte, Salim M. Hayek, Robert M. Levy
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
